Extended day prescription refills for hypertension can be a game changer for health service delivery… At an event organised by FPAI, to release a policy brief and set of recommendations from Banaras Hindu University, health experts…
Pharma companies need to limit the presence of nitrosamines in human medicines: EMA Patients should generally not be exposed to a lifetime risk of cancer exceeding 1 in 100,000 from nitrosamines in their medicines
